Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/23014
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2021-12-07T05:30:29Z | - |
dc.date.available | 2021-12-07T05:30:29Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Ülgen, M. vd. (2006). ''Urinary tract infections due to Mycoplasma canis in dogs''. Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine, 53(7), 379-382. | en_US |
dc.identifier.issn | 0931-184X | - |
dc.identifier.uri | https://doi.org/10.1111/j.1439-0442.2006.00858.x | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0442.2006.00858.x | - |
dc.identifier.uri | http://hdl.handle.net/11452/23014 | - |
dc.description.abstract | Urine samples were obtained from 100 dogs with symptoms of lower urinary tract disease by cystocentesis and were examined for mycoplasmas. Urinalysis, haematological and biochemical analyses were also performed. Bacteria were isolated from urine in 41 of 100 dogs; Mycoplasma canis was isolated from four of 100 (4%) urine samples and three were pure culture. Selective mycoplasma media were used for isolation. In growth inhibition test, propagation of the four M. canis isolates was inhibited by their specific hyperimmune sera and there was no cross reactivity between isolates and hyperimmune sera of other mycoplasmas. Dogs in which M. caniswas isolated were azotemic. All dogs were treated with enrofloxacin, furosemide, and supportive therapy (fluid therapy, ascorbic acid). In all animals, clinical improvements were observed after treatment. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-Blackwell Publishing | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Veterinary sciences | en_US |
dc.subject | Mycoplasmatales | en_US |
dc.subject | Mycoplasma canis | en_US |
dc.subject | Mycoplasma | en_US |
dc.subject | Canis familiaris | en_US |
dc.subject | Bacteria (microorganisms) | en_US |
dc.subject | Animalia | en_US |
dc.subject.mesh | Urinary tract infections | en_US |
dc.subject.mesh | Urinalysis | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Mycoplasma infections | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Dog diseases | en_US |
dc.subject.mesh | Blood chemical analysis | en_US |
dc.subject.mesh | Anti-bacterial agents | en_US |
dc.subject.mesh | Animals | en_US |
dc.title | Urinary tract infections due to Mycoplasma canis in dogs | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000240955000011 | tr_TR |
dc.identifier.scopus | 2-s2.0-33747480873 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Veteriner Fakültesi/Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-6307-5179 | tr_TR |
dc.identifier.startpage | 379 | tr_TR |
dc.identifier.endpage | 382 | tr_TR |
dc.identifier.volume | 53 | tr_TR |
dc.identifier.issue | 7 | tr_TR |
dc.relation.journal | Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine | en_US |
dc.contributor.buuauthor | Ülgen, Mihriban | - |
dc.contributor.buuauthor | Cam, Çetin | - |
dc.contributor.buuauthor | Şentürk, Şerife | - |
dc.contributor.buuauthor | Özel, Adil Emre | - |
dc.contributor.buuauthor | Özdemir, Ümit | - |
dc.contributor.researcherid | AAG-8117-2021 | tr_TR |
dc.contributor.researcherid | F-8820-2013 | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.identifier.pubmed | 16922838 | tr_TR |
dc.subject.wos | Veterinary sciences | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 56259664500 | tr_TR |
dc.contributor.scopusid | 7003489234 | tr_TR |
dc.contributor.scopusid | 56257771200 | tr_TR |
dc.contributor.scopusid | 14071585900 | tr_TR |
dc.contributor.scopusid | 8212139900 | tr_TR |
dc.subject.scopus | Canid Herpesvirus 1; Canine Coronavirus; Canine Distemper Virus | en_US |
dc.subject.emtree | Antiinfective agent | en_US |
dc.subject.emtree | Urinary tract infection | en_US |
dc.subject.emtree | Urinalysis | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Dog disease | en_US |
dc.subject.emtree | Dog | en_US |
dc.subject.emtree | Blood analysis | en_US |
dc.subject.emtree | Bacterial infection | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Animal disease | en_US |
dc.subject.emtree | Animal | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.